Company / Financials
Kraig Biocraft Laboratories, Inc. Financials
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
-
FY2019
Net Income
-$2.9M
FY2019 · -148.9% YoY
Profit Margin
-
FY2019 · net income / revenue
ROE
-
FY2019 · return on equity
Total Assets
$750.9K
FY2019
Total Debt
-
FY2019
Equity
-$5.4M
FY2019
ROA
-387.5%
FY2019 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -50.01 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations-Net Income HistoryProfit after all expenses and taxes-$2.9M-148.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$2.6M-173.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.4M+174.1% YoYR&D Expense HistoryResearch and development spending$223.1K+50.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$294.4K+28.6% YoYIncome Tax HistoryTotal income tax expense-EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.00Shares Outstanding HistoryWeighted average diluted shares outstanding816.9M+3.2% YoYTotal Assets HistoryTotal value of all assets owned$750.9K+951.9% YoY